| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 31-Dec-08 | | Total Revenue | 4,293 | 2,631 | 1,677 | 1,278 | | Cost of Revenue | 3,940 | 3,676 | 1,797 | 1,659 | | | Gross Profit | 353 | (1,045) | (120) | (381) | | | Operating Expenses | | Research Development | 902 | 429 | 1,653 | 1,689 | | Selling General and Administrative | 1,629 | 1,812 | 1,723 | 1,638 | | Non Recurring |
-
|
-
|
-
| 141 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,178) | (3,286) | (3,496) | (3,849) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 397 | (776) | 13 | 49 | | Earnings Before Interest And Taxes | (1,694) | (4,099) | (3,533) | (3,800) | | Interest Expense | 7 | 9 | 9 | 9 | | Income Before Tax | (1,701) | (4,108) | (3,542) | (3,809) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (30) | (37) | (50) |
-
| | | | Net Income From Continuing Ops | (1,818) | (4,108) | (3,542) | (3,809) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,818) | (4,108) | (3,542) | (3,809) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,818) | ($4,108) | ($3,542) | ($3,809) |
|
0.01% Nasdaq 
Income Statement
